Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Environment

Rebooting Mitochondria With Adenosine Monophosphate

Cell Metabolism: The cell’s powerhouse recycles when AMP signals an alarm

by Sarah Everts
January 18, 2016 | A version of this story appeared in Volume 94, Issue 3

Microscopy images of a healthy mitochondria and one in the process of recycling the organelle after exposure to a toxin.
Credit: Salk Institute for Biological Studies
When mitochondria (left) are exposed to the toxin rotenone and start to degrade, AMP signals the organelle to save useful components in vesicles and reboot (right).

When cell mitochondria are exposed to electron-transport-chain poisons such as rotenone, the chemical-energy-producing organelles reboot themselves. First, mitochondria reorganize their valuable biomolecular contents into smaller vesicles. This segregation allows mitochondria to initiate degradation and recycling of damaged machinery. If the repair is not sufficient, then the entire cell dies. But often mitochondria are rebuilt using both new and recycled molecules in a process called fragmentation. Researchers led by Reuben J. Shaw at the Salk Institute for Biological Studies have found that adenosine monophosphate (AMP) is a master switch for fragmentation (Science 2016, DOI: 10.1126/science.aab4138). AMP is produced when the mitochondria’s chemical energy currency, adenosine triphosphate, loses two energy-rich phosphate groups. Its presence is a signal that mitochondria may not be functioning efficiently. Shaw and his team discovered AMP’s rebooting role when they found that a protein kinase activated by AMP is sufficient to kick-start the fragmentation process. A better understanding of mitochondrial recycling may provide insight to scientists developing drugs for diseases that affect mitochondria, such as Parkinson’s disease.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.